Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes

Completed · Not applicable

Conditions studied: Diabetes

In brief

The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.

Key facts

Study ID

NCT02846779

Run by

Brigham and Women's Hospital

People needed

6000

Starts

2016-07-01

Expected to finish

2018-02-10

Last updated by the study team

2019-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Commercially-insured individuals receiving medical and pharmacy health insurance benefits from Horizon Blue Cross Blue Shield of New Jersey
• At least 3 months of continuous enrollment prior to randomization
• At least 1 prescription for basal insulin, 6 months prior to randomization
• Type 2 diabetes diagnosis

You may not qualify if…

• Patients with Medicaid or Medicare as primary insurance

Where it is running

• Horizon Blue Cross Blue Shield of New Jersey — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.